@xconomy.com 6 days ago
Bio Roundup: SeaGen Scores, Dyne’s Debut, Microbiome Moves & More
@xconomy.com 19 days ago
FDA Approves Blueprint Cancer Drug Targeting RET Genetic Signatures
@xconomy.com 2 months ago
Two Days, Six IPOs, and $1B Raised for Biotech Research & More
@xconomy.com 7 months ago
Revolution Medicines IPO Reels In $238M to Take On RAS in Cancer
@xconomy.com 8 months ago
Revolution Medicines Maps Out an IPO to Reach Cancer’s Frontiers
@xconomy.com 8 months ago
Schrödinger Sets Course for IPO to Support Growing Internal Pipeline
@xconomy.com 8 months ago
Black Diamond Lines Up IPO as Lead Cancer Drug Nears Clinic
@xconomy.com 12 months ago
Biotech Roundup: Vaping Toll Rises, NASH News, Akcea Shakeup & More
@xconomy.com 1 year ago
Bio Roundup: #JPM19 Notes, Loxo Buyout, Black Diamond’s Cash & More